StockNews.com upgraded shares of Cadiz (NASDAQ:CDZI – Free Report) to a sell rating in a research report sent to investors on Friday.
Cadiz Trading Up 2.5 %
Shares of CDZI opened at $3.32 on Friday. The business’s 50-day moving average price is $3.15 and its 200 day moving average price is $3.14. The company has a current ratio of 1.36, a quick ratio of 1.40 and a debt-to-equity ratio of 3.88. The stock has a market capitalization of $226.36 million, a P/E ratio of -6.51 and a beta of 0.85. Cadiz has a 1-year low of $2.12 and a 1-year high of $3.85.
Insider Buying and Selling
In other Cadiz news, major shareholder International Group Se Heerema purchased 2,070,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The shares were purchased at an average cost of $3.34 per share, with a total value of $6,913,800.00. Following the completion of the transaction, the insider now owns 22,783,965 shares of the company’s stock, valued at approximately $76,098,443.10. This represents a 9.99 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.70% of the company’s stock.
Hedge Funds Weigh In On Cadiz
About Cadiz
Cadiz Inc, together with its subsidiaries, provides water solutions in the United States. The company operates through Land and Water Resources; and Water Filtration Technology segments. It offers water supply, water storage, water conveyance, and water filtration services. In addition, the company is involved in the cultivation of grain crops and alfalfa, as well as provides water filtration solutions for impaired or contaminated groundwater sources.
See Also
- Five stocks we like better than Cadiz
- Best Stocks Under $5.00
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Invest in Blue Chip Stocks
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Cadiz Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cadiz and related companies with MarketBeat.com's FREE daily email newsletter.